nodes	percent_of_prediction	percent_of_DWPC	metapath
Dexamethasone—CYP17A1—melanoma	0.172	0.34	CbGaD
Dexamethasone—NOS2—melanoma	0.14	0.277	CbGaD
Dexamethasone—CYP1B1—melanoma	0.119	0.236	CbGaD
Dexamethasone—ABCG2—Vemurafenib—melanoma	0.0465	0.155	CbGbCtD
Dexamethasone—PTGS2—melanoma	0.0402	0.0796	CbGaD
Dexamethasone—ABCB1—melanoma	0.0342	0.0677	CbGaD
Dexamethasone—CYP1B1—Docetaxel—melanoma	0.0336	0.112	CbGbCtD
Dexamethasone—CYP1A1—Dacarbazine—melanoma	0.0329	0.11	CbGbCtD
Dexamethasone—ABCG2—Dactinomycin—melanoma	0.0309	0.103	CbGbCtD
Dexamethasone—CYP2E1—Dacarbazine—melanoma	0.0254	0.0848	CbGbCtD
Dexamethasone—CYP3A4—Temozolomide—melanoma	0.0183	0.0612	CbGbCtD
Dexamethasone—ABCC2—Docetaxel—melanoma	0.0176	0.0589	CbGbCtD
Dexamethasone—ABCG2—Docetaxel—melanoma	0.016	0.0532	CbGbCtD
Dexamethasone—CYP2D6—Vemurafenib—melanoma	0.0158	0.0527	CbGbCtD
Dexamethasone—CYP3A7—Docetaxel—melanoma	0.0118	0.0393	CbGbCtD
Dexamethasone—CYP3A7-CYP3A51P—Docetaxel—melanoma	0.0118	0.0393	CbGbCtD
Dexamethasone—ABCB1—Dactinomycin—melanoma	0.0111	0.0372	CbGbCtD
Dexamethasone—CYP3A4—Vemurafenib—melanoma	0.01	0.0335	CbGbCtD
Dexamethasone—CYP3A5—Docetaxel—melanoma	0.00884	0.0295	CbGbCtD
Dexamethasone—ABCB1—Docetaxel—melanoma	0.00575	0.0192	CbGbCtD
Dexamethasone—CYP3A4—Docetaxel—melanoma	0.00345	0.0115	CbGbCtD
Dexamethasone—PLA2G1B—blood vessel—melanoma	0.00141	0.0799	CbGeAlD
Dexamethasone—ANXA1—hair follicle—melanoma	0.00115	0.0652	CbGeAlD
Dexamethasone—ANXA1—neck—melanoma	0.000773	0.0437	CbGeAlD
Dexamethasone—PTGS2—leg—melanoma	0.000762	0.0431	CbGeAlD
Dexamethasone—PTGS2—hindlimb—melanoma	0.000681	0.0385	CbGeAlD
Dexamethasone—PGR—blood vessel—melanoma	0.000651	0.0368	CbGeAlD
Dexamethasone—PTGS2—appendage—melanoma	0.000584	0.033	CbGeAlD
Dexamethasone—CYP1B1—hair follicle—melanoma	0.000584	0.033	CbGeAlD
Dexamethasone—CYP1A1—skin epidermis—melanoma	0.000578	0.0327	CbGeAlD
Dexamethasone—ANXA1—eye—melanoma	0.000575	0.0325	CbGeAlD
Dexamethasone—ANXA1—skin of body—melanoma	0.000501	0.0283	CbGeAlD
Dexamethasone—PTGS2—skin epidermis—melanoma	0.000486	0.0275	CbGeAlD
Dexamethasone—ANXA1—mammalian vulva—melanoma	0.000456	0.0258	CbGeAlD
Dexamethasone—PLA2G1B—head—melanoma	0.000427	0.0241	CbGeAlD
Dexamethasone—NR3C2—retina—melanoma	0.000369	0.0209	CbGeAlD
Dexamethasone—Skin exfoliation—Temozolomide—melanoma	0.000368	0.005	CcSEcCtD
Dexamethasone—Neuropathy—Temozolomide—melanoma	0.000362	0.00492	CcSEcCtD
Dexamethasone—Injury—Bleomycin—melanoma	0.000361	0.00491	CcSEcCtD
Dexamethasone—Dry eye—Temozolomide—melanoma	0.000356	0.00484	CcSEcCtD
Dexamethasone—Eye disorder—Vemurafenib—melanoma	0.000354	0.00481	CcSEcCtD
Dexamethasone—PTGS2—endothelium—melanoma	0.000352	0.0199	CbGeAlD
Dexamethasone—Angiopathy—Vemurafenib—melanoma	0.000344	0.00467	CcSEcCtD
Dexamethasone—Neuritis—Docetaxel—melanoma	0.000343	0.00467	CcSEcCtD
Dexamethasone—Rash erythematous—Docetaxel—melanoma	0.000335	0.00455	CcSEcCtD
Dexamethasone—Alopecia—Vemurafenib—melanoma	0.000335	0.00455	CcSEcCtD
Dexamethasone—Thrombophlebitis—Carmustine—melanoma	0.000335	0.00455	CcSEcCtD
Dexamethasone—Diabetes mellitus—Carmustine—melanoma	0.000333	0.00452	CcSEcCtD
Dexamethasone—Erythema—Vemurafenib—melanoma	0.00033	0.00448	CcSEcCtD
Dexamethasone—Necrosis—Docetaxel—melanoma	0.000327	0.00444	CcSEcCtD
Dexamethasone—ANXA1—head—melanoma	0.000327	0.0185	CbGeAlD
Dexamethasone—PTGS2—blood vessel—melanoma	0.000325	0.0184	CbGeAlD
Dexamethasone—Thrombophlebitis—Temozolomide—melanoma	0.000323	0.00439	CcSEcCtD
Dexamethasone—Eye pain—Carmustine—melanoma	0.000321	0.00436	CcSEcCtD
Dexamethasone—Lethargy—Dactinomycin—melanoma	0.000316	0.00429	CcSEcCtD
Dexamethasone—Injury—Carmustine—melanoma	0.000315	0.00428	CcSEcCtD
Dexamethasone—Eye pain—Temozolomide—melanoma	0.00031	0.00421	CcSEcCtD
Dexamethasone—NR3C2—mammalian vulva—melanoma	0.000296	0.0167	CbGeAlD
Dexamethasone—Extravasation—Docetaxel—melanoma	0.000294	0.00399	CcSEcCtD
Dexamethasone—CYP17A1—head—melanoma	0.000293	0.0165	CbGeAlD
Dexamethasone—Amenorrhoea—Docetaxel—melanoma	0.000292	0.00397	CcSEcCtD
Dexamethasone—CYP1B1—eye—melanoma	0.000291	0.0165	CbGeAlD
Dexamethasone—Myalgia—Vemurafenib—melanoma	0.000281	0.00382	CcSEcCtD
Dexamethasone—Affect lability—Temozolomide—melanoma	0.000275	0.00374	CcSEcCtD
Dexamethasone—CYP11A1—head—melanoma	0.000272	0.0154	CbGeAlD
Dexamethasone—Anaphylactic shock—Vemurafenib—melanoma	0.000269	0.00366	CcSEcCtD
Dexamethasone—NR3C1—neck—melanoma	0.000269	0.0152	CbGeAlD
Dexamethasone—Infection—Vemurafenib—melanoma	0.000267	0.00363	CcSEcCtD
Dexamethasone—Mood swings—Temozolomide—melanoma	0.000265	0.0036	CcSEcCtD
Dexamethasone—Nervous system disorder—Vemurafenib—melanoma	0.000264	0.00359	CcSEcCtD
Dexamethasone—Hypokalaemia—Carmustine—melanoma	0.000264	0.00358	CcSEcCtD
Dexamethasone—Weight decreased—Bleomycin—melanoma	0.000259	0.00353	CcSEcCtD
Dexamethasone—Dry skin—Temozolomide—melanoma	0.000257	0.00349	CcSEcCtD
Dexamethasone—Muscular weakness—Carmustine—melanoma	0.000255	0.00347	CcSEcCtD
Dexamethasone—Hypokalaemia—Temozolomide—melanoma	0.000255	0.00346	CcSEcCtD
Dexamethasone—CYP1B1—skin of body—melanoma	0.000253	0.0143	CbGeAlD
Dexamethasone—Acute coronary syndrome—Bleomycin—melanoma	0.000252	0.00343	CcSEcCtD
Dexamethasone—Hypotension—Vemurafenib—melanoma	0.000252	0.00342	CcSEcCtD
Dexamethasone—Myocardial infarction—Bleomycin—melanoma	0.000251	0.00341	CcSEcCtD
Dexamethasone—Muscular weakness—Temozolomide—melanoma	0.000247	0.00335	CcSEcCtD
Dexamethasone—Musculoskeletal discomfort—Vemurafenib—melanoma	0.000245	0.00333	CcSEcCtD
Dexamethasone—Skin exfoliation—Docetaxel—melanoma	0.000245	0.00333	CcSEcCtD
Dexamethasone—Fluid retention—Docetaxel—melanoma	0.000243	0.00331	CcSEcCtD
Dexamethasone—Neuropathy—Docetaxel—melanoma	0.000241	0.00327	CcSEcCtD
Dexamethasone—Sweating increased—Temozolomide—melanoma	0.000236	0.0032	CcSEcCtD
Dexamethasone—Oesophagitis—Docetaxel—melanoma	0.000234	0.00318	CcSEcCtD
Dexamethasone—Decreased appetite—Vemurafenib—melanoma	0.000234	0.00318	CcSEcCtD
Dexamethasone—Gastrointestinal disorder—Vemurafenib—melanoma	0.000232	0.00316	CcSEcCtD
Dexamethasone—Fatigue—Vemurafenib—melanoma	0.000232	0.00315	CcSEcCtD
Dexamethasone—Haemoglobin—Bleomycin—melanoma	0.000231	0.00314	CcSEcCtD
Dexamethasone—Haemorrhage—Bleomycin—melanoma	0.00023	0.00312	CcSEcCtD
Dexamethasone—ANXA1—lymph node—melanoma	0.000229	0.0129	CbGeAlD
Dexamethasone—Pulmonary oedema—Docetaxel—melanoma	0.000228	0.0031	CcSEcCtD
Dexamethasone—Hyperglycaemia—Carmustine—melanoma	0.000226	0.00307	CcSEcCtD
Dexamethasone—Weight increased—Temozolomide—melanoma	0.00022	0.00299	CcSEcCtD
Dexamethasone—Weight decreased—Temozolomide—melanoma	0.000219	0.00297	CcSEcCtD
Dexamethasone—Neuropathy peripheral—Carmustine—melanoma	0.000219	0.00297	CcSEcCtD
Dexamethasone—Hyperglycaemia—Temozolomide—melanoma	0.000218	0.00297	CcSEcCtD
Dexamethasone—Thrombophlebitis—Docetaxel—melanoma	0.000215	0.00292	CcSEcCtD
Dexamethasone—Body temperature increased—Vemurafenib—melanoma	0.000213	0.00289	CcSEcCtD
Dexamethasone—NR3C2—head—melanoma	0.000211	0.012	CbGeAlD
Dexamethasone—Neuropathy peripheral—Temozolomide—melanoma	0.000211	0.00287	CcSEcCtD
Dexamethasone—Cardiac failure congestive—Docetaxel—melanoma	0.000205	0.00279	CcSEcCtD
Dexamethasone—CYP17A1—lymph node—melanoma	0.000205	0.0116	CbGeAlD
Dexamethasone—Alopecia—Bleomycin—melanoma	0.000203	0.00276	CcSEcCtD
Dexamethasone—Haemoglobin—Carmustine—melanoma	0.000201	0.00274	CcSEcCtD
Dexamethasone—ABCB1—blood vessel—melanoma	0.000201	0.0114	CbGeAlD
Dexamethasone—Haemorrhage—Carmustine—melanoma	0.0002	0.00272	CcSEcCtD
Dexamethasone—NR3C1—eye—melanoma	0.0002	0.0113	CbGeAlD
Dexamethasone—Erythema—Bleomycin—melanoma	0.0002	0.00272	CcSEcCtD
Dexamethasone—Hallucination—Carmustine—melanoma	0.000199	0.00271	CcSEcCtD
Dexamethasone—PGR—head—melanoma	0.000197	0.0111	CbGeAlD
Dexamethasone—Visual disturbance—Docetaxel—melanoma	0.000196	0.00267	CcSEcCtD
Dexamethasone—Dermatitis bullous—Docetaxel—melanoma	0.000195	0.00265	CcSEcCtD
Dexamethasone—Haemoglobin—Temozolomide—melanoma	0.000195	0.00264	CcSEcCtD
Dexamethasone—Haemorrhage—Temozolomide—melanoma	0.000194	0.00263	CcSEcCtD
Dexamethasone—Asthenia—Vemurafenib—melanoma	0.000193	0.00262	CcSEcCtD
Dexamethasone—Visual impairment—Carmustine—melanoma	0.000193	0.00262	CcSEcCtD
Dexamethasone—Hallucination—Temozolomide—melanoma	0.000193	0.00262	CcSEcCtD
Dexamethasone—Cardiac failure—Docetaxel—melanoma	0.000191	0.00259	CcSEcCtD
Dexamethasone—CYP11A1—lymph node—melanoma	0.000191	0.0108	CbGeAlD
Dexamethasone—Pruritus—Vemurafenib—melanoma	0.00019	0.00259	CcSEcCtD
Dexamethasone—Lethargy—Docetaxel—melanoma	0.00019	0.00258	CcSEcCtD
Dexamethasone—Alopecia—Dactinomycin—melanoma	0.000189	0.00257	CcSEcCtD
Dexamethasone—Eye disorder—Carmustine—melanoma	0.000187	0.00254	CcSEcCtD
Dexamethasone—Visual impairment—Temozolomide—melanoma	0.000187	0.00254	CcSEcCtD
Dexamethasone—Erythema—Dactinomycin—melanoma	0.000186	0.00253	CcSEcCtD
Dexamethasone—Ill-defined disorder—Bleomycin—melanoma	0.000185	0.00252	CcSEcCtD
Dexamethasone—Diarrhoea—Vemurafenib—melanoma	0.000184	0.0025	CcSEcCtD
Dexamethasone—Migraine—Docetaxel—melanoma	0.000183	0.00249	CcSEcCtD
Dexamethasone—SLCO1A2—head—melanoma	0.000181	0.0103	CbGeAlD
Dexamethasone—Eye disorder—Temozolomide—melanoma	0.000181	0.00246	CcSEcCtD
Dexamethasone—Malaise—Bleomycin—melanoma	0.00018	0.00245	CcSEcCtD
Dexamethasone—CYP1A1—skin of body—melanoma	0.000179	0.0101	CbGeAlD
Dexamethasone—Arrhythmia—Carmustine—melanoma	0.000179	0.00243	CcSEcCtD
Dexamethasone—Dizziness—Vemurafenib—melanoma	0.000178	0.00242	CcSEcCtD
Dexamethasone—Alopecia—Carmustine—melanoma	0.000177	0.00241	CcSEcCtD
Dexamethasone—CYP19A1—head—melanoma	0.000177	0.01	CbGeAlD
Dexamethasone—Angiopathy—Temozolomide—melanoma	0.000176	0.00239	CcSEcCtD
Dexamethasone—Erythema—Carmustine—melanoma	0.000174	0.00237	CcSEcCtD
Dexamethasone—CYP2B6—skin of body—melanoma	0.000174	0.00985	CbGeAlD
Dexamethasone—NR3C1—skin of body—melanoma	0.000174	0.00983	CbGeAlD
Dexamethasone—Ill-defined disorder—Dactinomycin—melanoma	0.000173	0.00235	CcSEcCtD
Dexamethasone—ABCG2—mammalian vulva—melanoma	0.000172	0.00973	CbGeAlD
Dexamethasone—Vomiting—Vemurafenib—melanoma	0.000171	0.00233	CcSEcCtD
Dexamethasone—Alopecia—Temozolomide—melanoma	0.000171	0.00233	CcSEcCtD
Dexamethasone—Dry skin—Docetaxel—melanoma	0.000171	0.00232	CcSEcCtD
Dexamethasone—Myalgia—Bleomycin—melanoma	0.00017	0.00231	CcSEcCtD
Dexamethasone—Rash—Vemurafenib—melanoma	0.00017	0.00231	CcSEcCtD
Dexamethasone—Dermatitis—Vemurafenib—melanoma	0.00017	0.0023	CcSEcCtD
Dexamethasone—Headache—Vemurafenib—melanoma	0.000169	0.00229	CcSEcCtD
Dexamethasone—Erythema—Temozolomide—melanoma	0.000169	0.00229	CcSEcCtD
Dexamethasone—Discomfort—Bleomycin—melanoma	0.000168	0.00228	CcSEcCtD
Dexamethasone—Malaise—Dactinomycin—melanoma	0.000168	0.00228	CcSEcCtD
Dexamethasone—CYP1B1—head—melanoma	0.000165	0.00935	CbGeAlD
Dexamethasone—CYP1A1—mammalian vulva—melanoma	0.000163	0.00924	CbGeAlD
Dexamethasone—Oedema—Bleomycin—melanoma	0.000163	0.00222	CcSEcCtD
Dexamethasone—Anaphylactic shock—Bleomycin—melanoma	0.000163	0.00222	CcSEcCtD
Dexamethasone—Infection—Bleomycin—melanoma	0.000162	0.0022	CcSEcCtD
Dexamethasone—Nausea—Vemurafenib—melanoma	0.00016	0.00217	CcSEcCtD
Dexamethasone—Thrombocytopenia—Bleomycin—melanoma	0.00016	0.00217	CcSEcCtD
Dexamethasone—Myalgia—Dactinomycin—melanoma	0.000159	0.00216	CcSEcCtD
Dexamethasone—NR3C1—mammalian vulva—melanoma	0.000159	0.00897	CbGeAlD
Dexamethasone—Discomfort—Dactinomycin—melanoma	0.000157	0.00213	CcSEcCtD
Dexamethasone—Ill-defined disorder—Temozolomide—melanoma	0.000156	0.00213	CcSEcCtD
Dexamethasone—Anorexia—Bleomycin—melanoma	0.000155	0.00211	CcSEcCtD
Dexamethasone—Angioedema—Temozolomide—melanoma	0.000154	0.00209	CcSEcCtD
Dexamethasone—Hypotension—Bleomycin—melanoma	0.000152	0.00207	CcSEcCtD
Dexamethasone—Oedema—Dactinomycin—melanoma	0.000152	0.00207	CcSEcCtD
Dexamethasone—Malaise—Temozolomide—melanoma	0.000152	0.00207	CcSEcCtD
Dexamethasone—Vertigo—Temozolomide—melanoma	0.000151	0.00206	CcSEcCtD
Dexamethasone—Convulsion—Carmustine—melanoma	0.000151	0.00205	CcSEcCtD
Dexamethasone—Infection—Dactinomycin—melanoma	0.000151	0.00205	CcSEcCtD
Dexamethasone—Hypertension—Carmustine—melanoma	0.000151	0.00205	CcSEcCtD
Dexamethasone—PTGS2—skin of body—melanoma	0.00015	0.00851	CbGeAlD
Dexamethasone—Thrombocytopenia—Dactinomycin—melanoma	0.000149	0.00202	CcSEcCtD
Dexamethasone—Musculoskeletal discomfort—Bleomycin—melanoma	0.000149	0.00202	CcSEcCtD
Dexamethasone—Myalgia—Carmustine—melanoma	0.000148	0.00202	CcSEcCtD
Dexamethasone—NR3C2—lymph node—melanoma	0.000148	0.00837	CbGeAlD
Dexamethasone—Anxiety—Carmustine—melanoma	0.000148	0.00201	CcSEcCtD
Dexamethasone—Paraesthesia—Bleomycin—melanoma	0.000146	0.00199	CcSEcCtD
Dexamethasone—Weight increased—Docetaxel—melanoma	0.000146	0.00199	CcSEcCtD
Dexamethasone—Convulsion—Temozolomide—melanoma	0.000146	0.00198	CcSEcCtD
Dexamethasone—Weight decreased—Docetaxel—melanoma	0.000146	0.00198	CcSEcCtD
Dexamethasone—Hypertension—Temozolomide—melanoma	0.000146	0.00198	CcSEcCtD
Dexamethasone—Anorexia—Dactinomycin—melanoma	0.000145	0.00197	CcSEcCtD
Dexamethasone—Myalgia—Temozolomide—melanoma	0.000143	0.00195	CcSEcCtD
Dexamethasone—Anxiety—Temozolomide—melanoma	0.000143	0.00194	CcSEcCtD
Dexamethasone—Oedema—Carmustine—melanoma	0.000142	0.00193	CcSEcCtD
Dexamethasone—Discomfort—Temozolomide—melanoma	0.000142	0.00193	CcSEcCtD
Dexamethasone—Decreased appetite—Bleomycin—melanoma	0.000142	0.00193	CcSEcCtD
Dexamethasone—Infection—Carmustine—melanoma	0.000141	0.00192	CcSEcCtD
Dexamethasone—Acute coronary syndrome—Docetaxel—melanoma	0.000141	0.00192	CcSEcCtD
Dexamethasone—Myocardial infarction—Docetaxel—melanoma	0.000141	0.00191	CcSEcCtD
Dexamethasone—Neuropathy peripheral—Docetaxel—melanoma	0.000141	0.00191	CcSEcCtD
Dexamethasone—Pain—Bleomycin—melanoma	0.000139	0.0019	CcSEcCtD
Dexamethasone—Conjunctivitis—Docetaxel—melanoma	0.000139	0.00189	CcSEcCtD
Dexamethasone—Thrombocytopenia—Carmustine—melanoma	0.000139	0.00189	CcSEcCtD
Dexamethasone—Tachycardia—Carmustine—melanoma	0.000139	0.00189	CcSEcCtD
Dexamethasone—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000139	0.00188	CcSEcCtD
Dexamethasone—PGR—lymph node—melanoma	0.000138	0.00778	CbGeAlD
Dexamethasone—Oedema—Temozolomide—melanoma	0.000138	0.00187	CcSEcCtD
Dexamethasone—Anaphylactic shock—Temozolomide—melanoma	0.000138	0.00187	CcSEcCtD
Dexamethasone—Infection—Temozolomide—melanoma	0.000137	0.00186	CcSEcCtD
Dexamethasone—Anorexia—Carmustine—melanoma	0.000136	0.00184	CcSEcCtD
Dexamethasone—Nervous system disorder—Temozolomide—melanoma	0.000135	0.00183	CcSEcCtD
Dexamethasone—Thrombocytopenia—Temozolomide—melanoma	0.000135	0.00183	CcSEcCtD
Dexamethasone—Feeling abnormal—Bleomycin—melanoma	0.000134	0.00183	CcSEcCtD
Dexamethasone—Hypotension—Carmustine—melanoma	0.000133	0.00181	CcSEcCtD
Dexamethasone—Hyperhidrosis—Temozolomide—melanoma	0.000133	0.00181	CcSEcCtD
Dexamethasone—Decreased appetite—Dactinomycin—melanoma	0.000132	0.0018	CcSEcCtD
Dexamethasone—Fatigue—Dactinomycin—melanoma	0.000131	0.00178	CcSEcCtD
Dexamethasone—Anorexia—Temozolomide—melanoma	0.000131	0.00178	CcSEcCtD
Dexamethasone—Pain—Dactinomycin—melanoma	0.00013	0.00177	CcSEcCtD
Dexamethasone—Musculoskeletal discomfort—Carmustine—melanoma	0.00013	0.00176	CcSEcCtD
Dexamethasone—Urticaria—Bleomycin—melanoma	0.00013	0.00176	CcSEcCtD
Dexamethasone—Haemoglobin—Docetaxel—melanoma	0.000129	0.00176	CcSEcCtD
Dexamethasone—Body temperature increased—Bleomycin—melanoma	0.000129	0.00175	CcSEcCtD
Dexamethasone—Haemorrhage—Docetaxel—melanoma	0.000129	0.00175	CcSEcCtD
Dexamethasone—Insomnia—Carmustine—melanoma	0.000129	0.00175	CcSEcCtD
Dexamethasone—Paraesthesia—Carmustine—melanoma	0.000128	0.00174	CcSEcCtD
Dexamethasone—Feeling abnormal—Dactinomycin—melanoma	0.000125	0.0017	CcSEcCtD
Dexamethasone—Musculoskeletal discomfort—Temozolomide—melanoma	0.000125	0.0017	CcSEcCtD
Dexamethasone—Insomnia—Temozolomide—melanoma	0.000124	0.00169	CcSEcCtD
Dexamethasone—Gastrointestinal pain—Dactinomycin—melanoma	0.000124	0.00169	CcSEcCtD
Dexamethasone—Visual impairment—Docetaxel—melanoma	0.000124	0.00169	CcSEcCtD
Dexamethasone—CYP19A1—lymph node—melanoma	0.000124	0.007	CbGeAlD
Dexamethasone—Decreased appetite—Carmustine—melanoma	0.000124	0.00168	CcSEcCtD
Dexamethasone—Paraesthesia—Temozolomide—melanoma	0.000124	0.00168	CcSEcCtD
Dexamethasone—Gastrointestinal disorder—Carmustine—melanoma	0.000123	0.00167	CcSEcCtD
Dexamethasone—Pain—Carmustine—melanoma	0.000122	0.00165	CcSEcCtD
Dexamethasone—Dyspepsia—Temozolomide—melanoma	0.000121	0.00165	CcSEcCtD
Dexamethasone—Eye disorder—Docetaxel—melanoma	0.00012	0.00164	CcSEcCtD
Dexamethasone—Abdominal pain—Dactinomycin—melanoma	0.00012	0.00163	CcSEcCtD
Dexamethasone—Body temperature increased—Dactinomycin—melanoma	0.00012	0.00163	CcSEcCtD
Dexamethasone—Decreased appetite—Temozolomide—melanoma	0.00012	0.00163	CcSEcCtD
Dexamethasone—Gastrointestinal disorder—Temozolomide—melanoma	0.000119	0.00161	CcSEcCtD
Dexamethasone—Fatigue—Temozolomide—melanoma	0.000119	0.00161	CcSEcCtD
Dexamethasone—ABCC2—lymph node—melanoma	0.000118	0.00669	CbGeAlD
Dexamethasone—Pain—Temozolomide—melanoma	0.000118	0.0016	CcSEcCtD
Dexamethasone—Feeling abnormal—Carmustine—melanoma	0.000117	0.00159	CcSEcCtD
Dexamethasone—Asthenia—Bleomycin—melanoma	0.000117	0.00159	CcSEcCtD
Dexamethasone—CYP1A1—head—melanoma	0.000117	0.00661	CbGeAlD
Dexamethasone—Angiopathy—Docetaxel—melanoma	0.000117	0.00159	CcSEcCtD
Dexamethasone—Gastrointestinal pain—Carmustine—melanoma	0.000116	0.00158	CcSEcCtD
Dexamethasone—CYP1B1—lymph node—melanoma	0.000116	0.00655	CbGeAlD
Dexamethasone—Pruritus—Bleomycin—melanoma	0.000115	0.00157	CcSEcCtD
Dexamethasone—Arrhythmia—Docetaxel—melanoma	0.000115	0.00156	CcSEcCtD
Dexamethasone—Alopecia—Docetaxel—melanoma	0.000114	0.00155	CcSEcCtD
Dexamethasone—CYP2B6—head—melanoma	0.000114	0.00642	CbGeAlD
Dexamethasone—NR3C1—head—melanoma	0.000113	0.00641	CbGeAlD
Dexamethasone—Feeling abnormal—Temozolomide—melanoma	0.000113	0.00154	CcSEcCtD
Dexamethasone—Abdominal pain—Carmustine—melanoma	0.000113	0.00153	CcSEcCtD
Dexamethasone—Body temperature increased—Carmustine—melanoma	0.000113	0.00153	CcSEcCtD
Dexamethasone—Gastrointestinal pain—Temozolomide—melanoma	0.000112	0.00153	CcSEcCtD
Dexamethasone—Erythema—Docetaxel—melanoma	0.000112	0.00152	CcSEcCtD
Dexamethasone—Urticaria—Temozolomide—melanoma	0.000109	0.00149	CcSEcCtD
Dexamethasone—Asthenia—Dactinomycin—melanoma	0.000109	0.00148	CcSEcCtD
Dexamethasone—Abdominal pain—Temozolomide—melanoma	0.000109	0.00148	CcSEcCtD
Dexamethasone—Body temperature increased—Temozolomide—melanoma	0.000109	0.00148	CcSEcCtD
Dexamethasone—CYP2E1—head—melanoma	0.000107	0.00603	CbGeAlD
Dexamethasone—ABCB1—retina—melanoma	0.000106	0.00599	CbGeAlD
Dexamethasone—Diarrhoea—Dactinomycin—melanoma	0.000104	0.00141	CcSEcCtD
Dexamethasone—Vomiting—Bleomycin—melanoma	0.000104	0.00141	CcSEcCtD
Dexamethasone—Rash—Bleomycin—melanoma	0.000103	0.0014	CcSEcCtD
Dexamethasone—Dermatitis—Bleomycin—melanoma	0.000103	0.0014	CcSEcCtD
Dexamethasone—Asthenia—Carmustine—melanoma	0.000102	0.00139	CcSEcCtD
Dexamethasone—Syncope—Docetaxel—melanoma	0.000101	0.00137	CcSEcCtD
Dexamethasone—Asthenia—Temozolomide—melanoma	9.87e-05	0.00134	CcSEcCtD
Dexamethasone—Loss of consciousness—Docetaxel—melanoma	9.85e-05	0.00134	CcSEcCtD
Dexamethasone—PTGS2—head—melanoma	9.82e-05	0.00555	CbGeAlD
Dexamethasone—Diarrhoea—Carmustine—melanoma	9.74e-05	0.00132	CcSEcCtD
Dexamethasone—Pruritus—Temozolomide—melanoma	9.73e-05	0.00132	CcSEcCtD
Dexamethasone—Convulsion—Docetaxel—melanoma	9.71e-05	0.00132	CcSEcCtD
Dexamethasone—Nausea—Bleomycin—melanoma	9.69e-05	0.00132	CcSEcCtD
Dexamethasone—Hypertension—Docetaxel—melanoma	9.68e-05	0.00132	CcSEcCtD
Dexamethasone—Vomiting—Dactinomycin—melanoma	9.67e-05	0.00131	CcSEcCtD
Dexamethasone—Rash—Dactinomycin—melanoma	9.59e-05	0.0013	CcSEcCtD
Dexamethasone—Myalgia—Docetaxel—melanoma	9.54e-05	0.0013	CcSEcCtD
Dexamethasone—Dizziness—Carmustine—melanoma	9.41e-05	0.00128	CcSEcCtD
Dexamethasone—Diarrhoea—Temozolomide—melanoma	9.41e-05	0.00128	CcSEcCtD
Dexamethasone—Oedema—Docetaxel—melanoma	9.15e-05	0.00124	CcSEcCtD
Dexamethasone—Anaphylactic shock—Docetaxel—melanoma	9.15e-05	0.00124	CcSEcCtD
Dexamethasone—Dizziness—Temozolomide—melanoma	9.1e-05	0.00124	CcSEcCtD
Dexamethasone—Infection—Docetaxel—melanoma	9.09e-05	0.00124	CcSEcCtD
Dexamethasone—Vomiting—Carmustine—melanoma	9.05e-05	0.00123	CcSEcCtD
Dexamethasone—Nausea—Dactinomycin—melanoma	9.03e-05	0.00123	CcSEcCtD
Dexamethasone—Shock—Docetaxel—melanoma	9e-05	0.00122	CcSEcCtD
Dexamethasone—Rash—Carmustine—melanoma	8.98e-05	0.00122	CcSEcCtD
Dexamethasone—Nervous system disorder—Docetaxel—melanoma	8.97e-05	0.00122	CcSEcCtD
Dexamethasone—Dermatitis—Carmustine—melanoma	8.97e-05	0.00122	CcSEcCtD
Dexamethasone—Thrombocytopenia—Docetaxel—melanoma	8.96e-05	0.00122	CcSEcCtD
Dexamethasone—Tachycardia—Docetaxel—melanoma	8.93e-05	0.00121	CcSEcCtD
Dexamethasone—Headache—Carmustine—melanoma	8.92e-05	0.00121	CcSEcCtD
Dexamethasone—Vomiting—Temozolomide—melanoma	8.75e-05	0.00119	CcSEcCtD
Dexamethasone—Anorexia—Docetaxel—melanoma	8.72e-05	0.00118	CcSEcCtD
Dexamethasone—Rash—Temozolomide—melanoma	8.67e-05	0.00118	CcSEcCtD
Dexamethasone—Dermatitis—Temozolomide—melanoma	8.67e-05	0.00118	CcSEcCtD
Dexamethasone—ABCG2—lymph node—melanoma	8.62e-05	0.00488	CbGeAlD
Dexamethasone—Headache—Temozolomide—melanoma	8.62e-05	0.00117	CcSEcCtD
Dexamethasone—Hypotension—Docetaxel—melanoma	8.55e-05	0.00116	CcSEcCtD
Dexamethasone—ABCB1—mammalian vulva—melanoma	8.49e-05	0.0048	CbGeAlD
Dexamethasone—Nausea—Carmustine—melanoma	8.46e-05	0.00115	CcSEcCtD
Dexamethasone—CYP2D6—head—melanoma	8.44e-05	0.00477	CbGeAlD
Dexamethasone—Musculoskeletal discomfort—Docetaxel—melanoma	8.33e-05	0.00113	CcSEcCtD
Dexamethasone—Insomnia—Docetaxel—melanoma	8.27e-05	0.00112	CcSEcCtD
Dexamethasone—Paraesthesia—Docetaxel—melanoma	8.21e-05	0.00112	CcSEcCtD
Dexamethasone—CYP1A1—lymph node—melanoma	8.19e-05	0.00463	CbGeAlD
Dexamethasone—Nausea—Temozolomide—melanoma	8.17e-05	0.00111	CcSEcCtD
Dexamethasone—Dyspepsia—Docetaxel—melanoma	8.05e-05	0.00109	CcSEcCtD
Dexamethasone—Decreased appetite—Docetaxel—melanoma	7.95e-05	0.00108	CcSEcCtD
Dexamethasone—NR3C1—lymph node—melanoma	7.94e-05	0.00449	CbGeAlD
Dexamethasone—Gastrointestinal disorder—Docetaxel—melanoma	7.9e-05	0.00107	CcSEcCtD
Dexamethasone—Fatigue—Docetaxel—melanoma	7.89e-05	0.00107	CcSEcCtD
Dexamethasone—Pain—Docetaxel—melanoma	7.82e-05	0.00106	CcSEcCtD
Dexamethasone—Feeling abnormal—Docetaxel—melanoma	7.54e-05	0.00102	CcSEcCtD
Dexamethasone—Gastrointestinal pain—Docetaxel—melanoma	7.48e-05	0.00102	CcSEcCtD
Dexamethasone—Abdominal pain—Docetaxel—melanoma	7.23e-05	0.000983	CcSEcCtD
Dexamethasone—Body temperature increased—Docetaxel—melanoma	7.23e-05	0.000983	CcSEcCtD
Dexamethasone—PTGS2—lymph node—melanoma	6.87e-05	0.00389	CbGeAlD
Dexamethasone—Asthenia—Docetaxel—melanoma	6.56e-05	0.000892	CcSEcCtD
Dexamethasone—Pruritus—Docetaxel—melanoma	6.47e-05	0.00088	CcSEcCtD
Dexamethasone—Diarrhoea—Docetaxel—melanoma	6.26e-05	0.000851	CcSEcCtD
Dexamethasone—ABCB1—head—melanoma	6.07e-05	0.00343	CbGeAlD
Dexamethasone—Dizziness—Docetaxel—melanoma	6.05e-05	0.000822	CcSEcCtD
Dexamethasone—Vomiting—Docetaxel—melanoma	5.82e-05	0.00079	CcSEcCtD
Dexamethasone—Rash—Docetaxel—melanoma	5.77e-05	0.000784	CcSEcCtD
Dexamethasone—Dermatitis—Docetaxel—melanoma	5.76e-05	0.000783	CcSEcCtD
Dexamethasone—Headache—Docetaxel—melanoma	5.73e-05	0.000779	CcSEcCtD
Dexamethasone—Nausea—Docetaxel—melanoma	5.43e-05	0.000738	CcSEcCtD
Dexamethasone—ABCB1—lymph node—melanoma	4.25e-05	0.0024	CbGeAlD
Dexamethasone—Fluticasone furoate—ABCB1—melanoma	3.12e-05	0.166	CrCbGaD
Dexamethasone—Methylprednisolone—ABCB1—melanoma	2.49e-05	0.132	CrCbGaD
Dexamethasone—Triamcinolone—PTGS2—melanoma	2.47e-05	0.131	CrCbGaD
Dexamethasone—Betamethasone—PTGS2—melanoma	2.02e-05	0.107	CrCbGaD
Dexamethasone—Prednisone—ALB—melanoma	1.99e-05	0.106	CrCbGaD
Dexamethasone—Prednisone—ABCB1—melanoma	1.9e-05	0.101	CrCbGaD
Dexamethasone—Prednisolone—ABCB1—melanoma	1.75e-05	0.0933	CrCbGaD
Dexamethasone—Betamethasone—ABCB1—melanoma	1.72e-05	0.0914	CrCbGaD
Dexamethasone—Hydrocortisone—ABCB1—melanoma	1.34e-05	0.0713	CrCbGaD
Dexamethasone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	2.53e-06	2.44e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—GNAQ—melanoma	2.52e-06	2.43e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—CD44—melanoma	2.52e-06	2.43e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—melanoma	2.51e-06	2.42e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—FASN—melanoma	2.5e-06	2.41e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—NOS2—melanoma	2.5e-06	2.41e-05	CbGpPWpGaD
Dexamethasone—CYP3A43—Metabolism—AKT1—melanoma	2.49e-06	2.41e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—ABCB1—melanoma	2.49e-06	2.41e-05	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—PRKCA—melanoma	2.48e-06	2.4e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—FASN—melanoma	2.48e-06	2.39e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—CYP1B1—melanoma	2.48e-06	2.39e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—NOTCH1—melanoma	2.47e-06	2.39e-05	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—ERCC2—melanoma	2.46e-06	2.38e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—SLC5A5—melanoma	2.46e-06	2.37e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—melanoma	2.45e-06	2.36e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—SLC5A5—melanoma	2.44e-06	2.35e-05	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—PRKCA—melanoma	2.43e-06	2.35e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—PRKCA—melanoma	2.43e-06	2.34e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—CD80—melanoma	2.42e-06	2.34e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—CYP1B1—melanoma	2.42e-06	2.33e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—APC—melanoma	2.42e-06	2.33e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—KIT—melanoma	2.42e-06	2.33e-05	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—ERCC2—melanoma	2.41e-06	2.33e-05	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—PIK3CG—melanoma	2.41e-06	2.33e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—ERCC2—melanoma	2.41e-06	2.32e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—EGF—melanoma	2.39e-06	2.31e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—GNAQ—melanoma	2.38e-06	2.29e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—CD44—melanoma	2.38e-06	2.29e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—GNAQ—melanoma	2.36e-06	2.27e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—CD44—melanoma	2.36e-06	2.27e-05	CbGpPWpGaD
Dexamethasone—CYP17A1—Metabolism—PIK3CA—melanoma	2.34e-06	2.25e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—PLA2G6—melanoma	2.33e-06	2.25e-05	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—PIK3CD—melanoma	2.33e-06	2.25e-05	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—PPARG—melanoma	2.33e-06	2.25e-05	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—PIK3CB—melanoma	2.32e-06	2.24e-05	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—PIK3CD—melanoma	2.31e-06	2.23e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—VEGFA—melanoma	2.31e-06	2.23e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	2.31e-06	2.23e-05	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—ALB—melanoma	2.3e-06	2.22e-05	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—PTGS2—melanoma	2.3e-06	2.22e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—PRKCA—melanoma	2.29e-06	2.21e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—STAT3—melanoma	2.29e-06	2.21e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—melanoma	2.29e-06	2.21e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—ABCB1—melanoma	2.28e-06	2.21e-05	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—ALB—melanoma	2.28e-06	2.2e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—NRAS—melanoma	2.28e-06	2.2e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—CYP1B1—melanoma	2.28e-06	2.2e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—ERCC2—melanoma	2.27e-06	2.2e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—BRAF—melanoma	2.27e-06	2.19e-05	CbGpPWpGaD
Dexamethasone—PGR—Gene Expression—AKT1—melanoma	2.27e-06	2.19e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—CYP1B1—melanoma	2.26e-06	2.18e-05	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—PIK3CB—melanoma	2.24e-06	2.16e-05	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—PTEN—melanoma	2.22e-06	2.14e-05	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—PTGS2—melanoma	2.21e-06	2.14e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—MAPK3—melanoma	2.19e-06	2.11e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—melanoma	2.19e-06	2.11e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—MAP2K1—melanoma	2.14e-06	2.06e-05	CbGpPWpGaD
Dexamethasone—CYP11A1—Metabolism—PIK3CA—melanoma	2.14e-06	2.06e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—MYC—melanoma	2.13e-06	2.05e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—PIK3CD—melanoma	2.12e-06	2.05e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	2.12e-06	2.05e-05	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—PIK3CD—melanoma	2.12e-06	2.05e-05	CbGpPWpGaD
Dexamethasone—CYP4A11—Metabolism—PIK3CA—melanoma	2.11e-06	2.04e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—PRKCA—melanoma	2.1e-06	2.03e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—VCAN—melanoma	2.1e-06	2.02e-05	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—ALB—melanoma	2.09e-06	2.02e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—ERCC2—melanoma	2.09e-06	2.01e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—MAPK1—melanoma	2.08e-06	2.01e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—EGFR—melanoma	2.08e-06	2.01e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—ABCB1—melanoma	2.04e-06	1.97e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—FGF2—melanoma	2.03e-06	1.96e-05	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—PIK3CB—melanoma	2.03e-06	1.96e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—PIK3CG—melanoma	2.02e-06	1.95e-05	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—PIK3CB—melanoma	2.02e-06	1.95e-05	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—PTGS2—melanoma	2.01e-06	1.95e-05	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—PTEN—melanoma	2.01e-06	1.94e-05	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—PTGS2—melanoma	2e-06	1.93e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.99e-06	1.92e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—KRAS—melanoma	1.96e-06	1.9e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—PPARG—melanoma	1.95e-06	1.89e-05	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—PIK3CG—melanoma	1.95e-06	1.88e-05	CbGpPWpGaD
Dexamethasone—NR3C1—Gene Expression—MAPK3—melanoma	1.94e-06	1.88e-05	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—PTEN—melanoma	1.93e-06	1.86e-05	CbGpPWpGaD
Dexamethasone—CYP17A1—Metabolism—AKT1—melanoma	1.91e-06	1.84e-05	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—PIK3CG—melanoma	1.91e-06	1.84e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—MDM2—melanoma	1.9e-06	1.84e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—PIK3CG—melanoma	1.9e-06	1.84e-05	CbGpPWpGaD
Dexamethasone—NR3C1—Gene Expression—MYC—melanoma	1.89e-06	1.82e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.88e-06	1.82e-05	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—PPARG—melanoma	1.88e-06	1.81e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—PRKCA—melanoma	1.88e-06	1.81e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—ERBB2—melanoma	1.88e-06	1.81e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—ABCB1—melanoma	1.88e-06	1.81e-05	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism—PIK3CA—melanoma	1.88e-06	1.81e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—ERCC2—melanoma	1.86e-06	1.8e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—ABCB1—melanoma	1.86e-06	1.8e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—PIK3CB—melanoma	1.85e-06	1.79e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—CD4—melanoma	1.85e-06	1.78e-05	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—PIK3CB—melanoma	1.85e-06	1.78e-05	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—PPARG—melanoma	1.84e-06	1.78e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—PPARG—melanoma	1.84e-06	1.77e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—PRKCA—melanoma	1.83e-06	1.77e-05	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—PTGS2—melanoma	1.83e-06	1.77e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—ERCC2—melanoma	1.82e-06	1.75e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—PIK3CA—melanoma	1.8e-06	1.74e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—PIK3CG—melanoma	1.8e-06	1.73e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—PIK3CD—melanoma	1.78e-06	1.72e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—CYP17A1—melanoma	1.77e-06	1.71e-05	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—PTEN—melanoma	1.76e-06	1.7e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—ALB—melanoma	1.76e-06	1.7e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—TP53—melanoma	1.75e-06	1.69e-05	CbGpPWpGaD
Dexamethasone—CYP11A1—Metabolism—AKT1—melanoma	1.74e-06	1.68e-05	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—PTEN—melanoma	1.74e-06	1.68e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—CDKN1B—melanoma	1.74e-06	1.68e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—PPARG—melanoma	1.73e-06	1.67e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.73e-06	1.67e-05	CbGpPWpGaD
Dexamethasone—CYP4A11—Metabolism—AKT1—melanoma	1.73e-06	1.67e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—PRKCA—melanoma	1.73e-06	1.67e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—ERCC2—melanoma	1.71e-06	1.65e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—PRKCA—melanoma	1.71e-06	1.65e-05	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—PIK3CD—melanoma	1.71e-06	1.65e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—ERCC2—melanoma	1.7e-06	1.64e-05	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—ALB—melanoma	1.69e-06	1.63e-05	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—PIK3CD—melanoma	1.67e-06	1.62e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—PIK3CD—melanoma	1.67e-06	1.61e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—GNA11—melanoma	1.67e-06	1.61e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—HRAS—melanoma	1.67e-06	1.61e-05	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—ALB—melanoma	1.65e-06	1.6e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—ALB—melanoma	1.65e-06	1.59e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—PIK3CG—melanoma	1.65e-06	1.59e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—CTNNB1—melanoma	1.64e-06	1.59e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—FASN—melanoma	1.63e-06	1.58e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—SLC5A5—melanoma	1.61e-06	1.55e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—CDKN1A—melanoma	1.6e-06	1.55e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—PTEN—melanoma	1.6e-06	1.54e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—IL6—melanoma	1.6e-06	1.54e-05	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—PTEN—melanoma	1.6e-06	1.54e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—PPARG—melanoma	1.59e-06	1.53e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—PIK3CD—melanoma	1.58e-06	1.52e-05	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—PIK3CA—melanoma	1.57e-06	1.51e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—ALB—melanoma	1.56e-06	1.51e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—GNAQ—melanoma	1.55e-06	1.5e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—CD44—melanoma	1.55e-06	1.5e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—PIK3CB—melanoma	1.55e-06	1.5e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.54e-06	1.49e-05	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism—AKT1—melanoma	1.53e-06	1.48e-05	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—PIK3CB—melanoma	1.49e-06	1.44e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—CYP1B1—melanoma	1.49e-06	1.44e-05	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—PTGS2—melanoma	1.48e-06	1.43e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—AKT1—melanoma	1.47e-06	1.42e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—PIK3CG—melanoma	1.47e-06	1.42e-05	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—PIK3CB—melanoma	1.46e-06	1.41e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—PIK3CB—melanoma	1.46e-06	1.41e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—PIK3CD—melanoma	1.45e-06	1.4e-05	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—PTGS2—melanoma	1.45e-06	1.4e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—PTGS2—melanoma	1.44e-06	1.39e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—PIK3CG—melanoma	1.43e-06	1.39e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—STAT3—melanoma	1.43e-06	1.38e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—ALB—melanoma	1.43e-06	1.38e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—NRAS—melanoma	1.43e-06	1.38e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—PPARG—melanoma	1.42e-06	1.37e-05	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—PIK3CA—melanoma	1.41e-06	1.37e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.41e-06	1.36e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—PPARG—melanoma	1.38e-06	1.34e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—PIK3CB—melanoma	1.38e-06	1.33e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—MAPK3—melanoma	1.37e-06	1.32e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—PTGS2—melanoma	1.36e-06	1.32e-05	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—PIK3CA—melanoma	1.36e-06	1.32e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—PIK3CG—melanoma	1.35e-06	1.31e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—PIK3CG—melanoma	1.34e-06	1.29e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—PTEN—melanoma	1.34e-06	1.29e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—MYC—melanoma	1.33e-06	1.28e-05	CbGpPWpGaD
Dexamethasone—NR3C1—Gene Expression—AKT1—melanoma	1.31e-06	1.27e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—PPARG—melanoma	1.3e-06	1.26e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—MAPK1—melanoma	1.3e-06	1.26e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—EGFR—melanoma	1.3e-06	1.26e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—PPARG—melanoma	1.29e-06	1.25e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—PIK3CD—melanoma	1.29e-06	1.25e-05	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—PTEN—melanoma	1.29e-06	1.24e-05	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—AKT1—melanoma	1.28e-06	1.23e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—ALB—melanoma	1.28e-06	1.23e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—PIK3CB—melanoma	1.26e-06	1.22e-05	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—PTEN—melanoma	1.26e-06	1.22e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—PIK3CD—melanoma	1.26e-06	1.22e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—PTEN—melanoma	1.26e-06	1.22e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—PTGS2—melanoma	1.25e-06	1.21e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—ALB—melanoma	1.25e-06	1.2e-05	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—PIK3CA—melanoma	1.24e-06	1.2e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—KRAS—melanoma	1.23e-06	1.19e-05	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—PIK3CA—melanoma	1.23e-06	1.19e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—ABCB1—melanoma	1.23e-06	1.18e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—PTEN—melanoma	1.19e-06	1.15e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—PIK3CD—melanoma	1.19e-06	1.15e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—PIK3CD—melanoma	1.18e-06	1.14e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—ALB—melanoma	1.17e-06	1.13e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—ALB—melanoma	1.16e-06	1.12e-05	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—AKT1—melanoma	1.16e-06	1.12e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—PIK3CA—melanoma	1.13e-06	1.09e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—PRKCA—melanoma	1.13e-06	1.09e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—PIK3CB—melanoma	1.13e-06	1.09e-05	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—PIK3CA—melanoma	1.13e-06	1.09e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—ERCC2—melanoma	1.12e-06	1.08e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—PTGS2—melanoma	1.12e-06	1.08e-05	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—AKT1—melanoma	1.11e-06	1.07e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—PIK3CB—melanoma	1.1e-06	1.06e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—PTEN—melanoma	1.09e-06	1.05e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—PTGS2—melanoma	1.09e-06	1.05e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—HRAS—melanoma	1.04e-06	1.01e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—PIK3CB—melanoma	1.04e-06	1e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—PIK3CB—melanoma	1.03e-06	9.92e-06	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—PTGS2—melanoma	1.03e-06	9.91e-06	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—PTGS2—melanoma	1.02e-06	9.82e-06	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—AKT1—melanoma	1.01e-06	9.78e-06	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—AKT1—melanoma	1e-06	9.69e-06	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—IL6—melanoma	1e-06	9.65e-06	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—PTEN—melanoma	9.73e-07	9.4e-06	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—PTEN—melanoma	9.5e-07	9.17e-06	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—PIK3CA—melanoma	9.45e-07	9.13e-06	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—AKT1—melanoma	9.22e-07	8.9e-06	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—AKT1—melanoma	9.2e-07	8.88e-06	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—PIK3CA—melanoma	9.09e-07	8.77e-06	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—PTEN—melanoma	8.95e-07	8.64e-06	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—PIK3CA—melanoma	8.9e-07	8.59e-06	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—PIK3CA—melanoma	8.88e-07	8.57e-06	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—PTEN—melanoma	8.87e-07	8.57e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—PIK3CG—melanoma	8.84e-07	8.53e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—PPARG—melanoma	8.53e-07	8.24e-06	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—PIK3CA—melanoma	8.39e-07	8.1e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—PIK3CD—melanoma	7.77e-07	7.5e-06	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—AKT1—melanoma	7.72e-07	7.46e-06	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—PIK3CA—melanoma	7.69e-07	7.43e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—ALB—melanoma	7.67e-07	7.41e-06	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—AKT1—melanoma	7.42e-07	7.17e-06	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—AKT1—melanoma	7.27e-07	7.02e-06	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—AKT1—melanoma	7.26e-07	7e-06	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—PIK3CA—melanoma	6.87e-07	6.63e-06	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—AKT1—melanoma	6.85e-07	6.62e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—PIK3CB—melanoma	6.77e-07	6.54e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—PTGS2—melanoma	6.71e-07	6.48e-06	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—PIK3CA—melanoma	6.7e-07	6.47e-06	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—PIK3CA—melanoma	6.32e-07	6.1e-06	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—AKT1—melanoma	6.28e-07	6.07e-06	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—PIK3CA—melanoma	6.26e-07	6.04e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—PTEN—melanoma	5.85e-07	5.65e-06	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—AKT1—melanoma	5.61e-07	5.42e-06	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—AKT1—melanoma	5.47e-07	5.29e-06	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—AKT1—melanoma	5.16e-07	4.98e-06	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—AKT1—melanoma	5.11e-07	4.94e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—PIK3CA—melanoma	4.13e-07	3.99e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—AKT1—melanoma	3.37e-07	3.26e-06	CbGpPWpGaD
